BDBM50510284 CHEMBL4461333::US10711036, Compound 101
SMILES: CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)CF
InChI Key: InChIKey=PYBHTUWIUGYAGW-ZJOUEHCJSA-N
Data: 2 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MALT lymphoma-associated translocation (MALT1) (Homo sapiens (Human)) | BDBM50510284 (CHEMBL4461333 | US10711036, Compound 101) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cornell University; Dana-Farber Cancer Institute, Inc.; Children''s Medical Center Corporation US Patent | Assay Description For exemplary compounds of the disclosure, Ki for inhibition of MALT1 was measured (Table E11). A concentration of 100 nM MALT1 was used for the assa... | US Patent US10711036 (2020) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
MALT lymphoma-associated translocation (MALT1) (Homo sapiens (Human)) | BDBM50510284 (CHEMBL4461333 | US10711036, Compound 101) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | 40 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Harvard Medical School Curated by ChEMBL | Assay Description Inhibition of recombinant LZ-fused MALT1 (340 to 789 residues) (unknown origin) using Ac-LRSR-AMC as substrate by fluorescence assay | Bioorg Med Chem Lett 29: 1336-1339 (2019) Article DOI: 10.1016/j.bmcl.2019.03.046 | |||||||||||
More data for this Ligand-Target Pair |